Answers are grounded in this paper and cite their sources.
The supply of any successful vaccine for coronavirus disease 2019 (COVID-19) will initially be limited. Who should have access first? The US National Academy of Medicine (NAM) has proposed a framework for COVID-19 vaccine allocation. Others have discussed distributing vaccine among countries. This Viewpoint delineates how ethical values should guide prioritization of a COVID-19 vaccine among populations within the US. The discussion may be relevant to other countries as well.
No takes yet. Share an insight, caveat, or question.
Persad et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: